MIRA Pharmaceuticals
MIRA
11 hedge funds and large institutions have $704K invested in MIRA Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 1 increasing their positions, reducing their positions, and 4 closing their positions.
590% more capital invested
Capital invested by funds: $102K → $704K (+$602K)
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
83% more funds holding
Funds holding: 6 → 11 (+5)
3.68% more ownership
Funds ownership: 0.66% → 4.34% (+3.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CSI
Cross Staff Investments
Pittsford,
New York
|
+$416K |
| 2 |
VF
Virtu Financial
New York
|
+$52.5K |
| 3 |
SEM
Suncoast Equity Management
Tampa,
Florida
|
+$43.4K |
| 4 |
HF
HRT Financial
New York
|
+$33.3K |
| 5 |
PWM
Praetorian Wealth Management
Carmel,
California
|
+$29.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
GTS Securities
Miami,
Florida
|
-$39.7K |
| 2 |
AWM
AE Wealth Management
Topeka,
Kansas
|
-$10.9K |
| 3 |
SSB
Sandy Spring Bank
Olney,
Maryland
|
-$10.9K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$4K |
MIRA Hedge Fund Activity: Q1 2024 in Review
11 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in MIRA Pharmaceuticals (MIRA) for Q1 2024, worth a combined $704K — up 590% from $102K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new MIRA positions and 4 closed out — a net gain of 5 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Cross Staff Investments, opening a new position worth an estimated $416K. The largest seller was GTS Securities, exiting entirely with an estimated $39.7K sold.
- 11 institutional investors held MIRA Pharmaceuticals (MIRA) as of Q1 2024, up from 6 in Q4 2023.
- Funds reported $704K of MIRA Pharmaceuticals stock for Q1 2024, up 590% quarter-over-quarter.
- 9 funds opened new MIRA Pharmaceuticals positions in Q1 2024 and 4 closed out, a net change of +5 holders.
- The largest MIRA Pharmaceuticals buyer in Q1 2024 was Cross Staff Investments, an estimated $416K added.
- The largest MIRA Pharmaceuticals seller in Q1 2024 was GTS Securities, an estimated $39.7K sold.
Based on aggregated 13F filings for Q1 2024.